157 related articles for article (PubMed ID: 10756665)
1. [Oral contraceptives and activated protein C resistance: a paradigmatic example of genotype and environment interaction in the development of deep venous thrombosis].
Panzini E; Raffa S; Miconi R; Lozzi A; Marci M
Clin Ter; 1999; 150(6):445-7. PubMed ID: 10756665
[TBL] [Abstract][Full Text] [Related]
2. APC resistance, oral contraceptive therapy and deep vein thrombosis: settled and unsettled problems.
Girolami A; Simioni P; Tormene D
Haematologica; 2000 Mar; 85(3):225-6. PubMed ID: 10702806
[No Abstract] [Full Text] [Related]
3. Cardiology patient page. Factor V Leiden.
Ornstein DL; Cushman M
Circulation; 2003 Apr; 107(15):e94-7. PubMed ID: 12707252
[No Abstract] [Full Text] [Related]
4. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
[TBL] [Abstract][Full Text] [Related]
5. [From pill to pill: oral contraception, venous thrombosis and coagulation disorders].
Vandenbroucke JP
Verh K Acad Geneeskd Belg; 2001; 63(3):243-52; discussion 252-5. PubMed ID: 11499345
[TBL] [Abstract][Full Text] [Related]
6. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
7. Activated protein C resistance due to factor V Leiden, elevated coagulation factor VIII and postoperative deep vein thrombosis in late breast reconstruction with a free TRAM flap: a report of two cases.
Olsson E; Höijer P
Br J Plast Surg; 2005 Jul; 58(5):720-3. PubMed ID: 15992531
[TBL] [Abstract][Full Text] [Related]
8. Factor V Leiden and contraception.
Ament L
J Midwifery Womens Health; 2004; 49(1):51-2. PubMed ID: 14710141
[TBL] [Abstract][Full Text] [Related]
9. Venous thrombosis, oral contraceptives and high factor VIII levels.
Bloemenkamp KW; Helmerhorst FM; Rosendaal FR; Vandenbroucke JP
Thromb Haemost; 1999 Sep; 82(3):1024-7. PubMed ID: 10494758
[TBL] [Abstract][Full Text] [Related]
10. Thrombosis: new culprits in an old disorder.
Federman DG; Moriarty JP; Kravetz JD; Kirsner RS
Panminerva Med; 2002 Jun; 44(2):107-13. PubMed ID: 12032428
[TBL] [Abstract][Full Text] [Related]
11. Oral contraceptive use in women with poor anticoagulant response to activated protein C but not carrying the factor V Leiden mutation increases the risk of venous thrombosis.
Legnani C; Cini M; Cosmi B; Mattarozzi S; Lo Manto G; Palareti G
Thromb Haemost; 2004 Apr; 91(4):712-8. PubMed ID: 15045132
[TBL] [Abstract][Full Text] [Related]
12. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in the protein C gene as risk factor for venous thrombosis.
Pomp ER; Doggen CJ; Vos HL; Reitsma PH; Rosendaal FR
Thromb Haemost; 2009 Jan; 101(1):62-7. PubMed ID: 19132190
[TBL] [Abstract][Full Text] [Related]
14. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population.
Torres JD; Cardona H; Alvarez L; Cardona-Maya W; Castañeda SA; Quintero-Rivera F; Cadavid A; Bedoya G; Tobón L
Am J Hematol; 2006 Dec; 81(12):933-7. PubMed ID: 16917913
[TBL] [Abstract][Full Text] [Related]
15. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
[TBL] [Abstract][Full Text] [Related]
16. Oral contraceptive pills and inherited thrombophilia in a young woman with deep venous thrombosis.
Mahfouz RA; Otrock ZK; Ghasham MA; Sabbagh AS; Taher AT; Bazarbachi A
East Mediterr Health J; 2009; 15(1):235-8. PubMed ID: 19469449
[No Abstract] [Full Text] [Related]
17. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
Wåhlander K; Larson G; Lindahl TL; Andersson C; Frison L; Gustafsson D; Bylock A; Eriksson BI
Thromb Haemost; 2002 Apr; 87(4):580-5. PubMed ID: 12008938
[TBL] [Abstract][Full Text] [Related]
18. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE
Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
[TBL] [Abstract][Full Text] [Related]
19. No interaction between factor V Leiden and hyperhomocysteinemia or MTHFR 677TT genotype in venous thrombosis. Results of a meta-analysis of published studies and a large case-only study.
Keijzer MB; Borm GF; Blom HJ; Bos GM; Rosendaal FR; den Heijer M
Thromb Haemost; 2007 Jan; 97(1):32-7. PubMed ID: 17200768
[TBL] [Abstract][Full Text] [Related]
20. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
de Visser MC; Guasch JF; Kamphuisen PW; Vos HL; Rosendaal FR; Bertina RM
Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]